Related Experiment Videos

[Clinical effects of meropenem on infectious diseases in obstetrics and gynecology]

T Chimura1, K Murayama, T Oda

  • 1Shirataka Hospital.

The Japanese Journal of Antibiotics
|March 28, 2001
PubMed

Insights

Meropenem (MEPM) demonstrated high efficacy and safety in obstetric and gynecological infections, achieving a 97.4% response rate across pregnant and non-pregnant patients. This broad-spectrum antibiotic proved effective even in cases resistant to prior treatments.

Area of Science:

  • Obstetrics and Gynecology
  • Infectious Diseases
  • Pharmacology

Background:

  • Obstetric and gynecological infections pose significant health risks.
  • Effective antibiotic therapy is crucial for managing these infections.
  • Meropenem (MEPM) is a broad-spectrum carbapenem antibiotic.

Purpose of the Study:

  • To evaluate the efficacy and safety of meropenem (MEPM) in treating obstetric and gynecological infections.
  • To assess MEPM's effectiveness in different patient populations (non-pregnant, pregnant, puerperal).
  • To determine MEPM's response rates in cases refractory to previous treatments.

Main Methods:

  • Intravenous drip infusion of meropenem (MEPM) at daily doses of 1-2 g.
  • Patient groups included non-pregnant (n=14), pregnant (n=13), and puerperal (n=11) periods.
  • Efficacy assessed by response rates, clinical outcomes, and bacterial eradication.

Main Results:

  • Overall response rate was 97.4% (38/39 patients).
  • Excellent and effective responses were observed in 33.3% and 64.1% of patients, respectively.
  • 100% response rate in patients refractory to prior treatments and in pregnant/puerperal groups.

Conclusions:

  • Meropenem (MEPM) is highly effective and safe for obstetric and gynecological infections.
  • The drug shows excellent efficacy across different patient populations and infection severities.
  • No adverse reactions or laboratory abnormalities were reported, highlighting MEPM's favorable safety profile.

Related Concept Videos

Microbiota Modulation by Antibiotics01:21

Microbiota Modulation by Antibiotics

Antibiotics have revolutionized modern medicine by saving countless lives from bacterial infections. However, their widespread use has inadvertently harmed the delicate balance of the human gut microbiota. The gut microbiota, a complex community of bacteria, archaea, viruses, and fungi, plays a vital role in regulating metabolism, immune responses, and maintaining intestinal health. Antibiotics, especially broad-spectrum types, disrupt this ecosystem by eradicating both harmful and beneficial...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Inhibitors of Bacterial DNA Synthesis01:28

Inhibitors of Bacterial DNA Synthesis

Bacterial pathogens depend on precise and efficient DNA replication to sustain infection. Two type II topoisomerases—DNA gyrase and topoisomerase IV—are critical to this process, as they resolve DNA supercoiling and unlink chromosomes during replication. Fluoroquinolones, synthetic derivatives of quinolones, exploit this mechanism by stabilizing the transient DNA–enzyme cleavage complex, preventing strand religation, and causing lethal double-strand breaks. These antibiotics are selectively...
Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Development of the Oral Microbiota01:28

Development of the Oral Microbiota

The establishment of the oral microbiome begins before birth, challenging the long-held belief that the fetal oral cavity is sterile. The presence of oral microbes such as Streptococcus and Fusobacterium in amniotic fluid suggests that microbial exposure may occur in utero, potentially through translocation from the maternal oral or gastrointestinal tract. This early colonization primes the neonatal immune system and sets the stage for subsequent microbial succession. Maternal health,...